603229 奧翔藥業
按盤價 
8.430 +0.020 (+0.238%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 10.325 | 14.095 | 17.333 | 12.254 | 9.800 |
| 總資產報酬率 ROA (%) | 7.672 | 9.641 | 11.330 | 9.061 | 7.658 |
| 投入資產回報率 ROIC (%) | 8.665 | 11.433 | 13.573 | 10.326 | 6.951 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.940 | 55.048 | 51.501 | 54.787 | 56.434 |
| 營業利潤率 (%) | 37.952 | 35.607 | 33.708 | 28.112 | 23.608 |
| 息稅前利潤/營業總收入 (%) | 37.198 | 31.479 | 27.939 | 28.989 | 27.163 |
| 淨利潤/營業總收入 (%) | 33.180 | 31.086 | 30.786 | 25.615 | 21.218 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.047 | 96.382 | 98.049 | 95.144 | 100.579 |
| 價值變動淨收益/利潤總額(%) | 4.502 | 0.241 | 2.473 | 7.317 | -4.871 |
| 營業外收支淨額/利潤總額(%) | -0.245 | -0.021 | -0.725 | -0.477 | -1.168 | 償債能力分析 |
| 流動比率 (X) | 2.530 | 2.172 | 1.525 | 1.924 | 4.018 |
| 速動比率 (X) | 2.001 | 1.699 | 1.095 | 1.465 | 3.238 |
| 資產負債率 (%) | 23.978 | 27.443 | 36.893 | 31.783 | 18.442 |
| 帶息債務/全部投入資本 (%) | 14.322 | 14.951 | 20.263 | 20.519 | -- |
| 股東權益/帶息債務 (%) | 588.673 | 558.661 | 384.038 | 384.451 | 1,150.875 |
| 股東權益/負債合計 (%) | 317.052 | 264.394 | 171.056 | 214.630 | 442.250 |
| 利息保障倍數 (X) | -56.254 | -7.639 | -5.056 | 28.669 | 7.095 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.428 | 58.966 | 47.334 | 35.325 | 0.000 |
| 存貨周轉天數 (天) | 338.834 | 336.194 | 273.793 | 303.018 | 0.000 |
| 備註： | 即時報價更新時間為 04/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
